Acorah Software Products - Accounts Production 19.2.450 false true 31 March 2025 1 April 2024 false true No description of principal activity 1 April 2025 31 March 2026 31 March 2026 14734440 Dr Vasileios Panoulas iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14734440 2025-03-31 14734440 2026-03-31 14734440 2025-04-01 2026-03-31 14734440 frs-core:CurrentFinancialInstruments 2026-03-31 14734440 frs-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 14734440 frs-bus:FilletedAccounts 2025-04-01 2026-03-31 14734440 frs-bus:Micro-entities 2025-04-01 2026-03-31 14734440 frs-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 14734440 frs-bus:Director1 2025-04-01 2026-03-31 14734440 frs-bus:Director1 2025-03-31 14734440 frs-bus:Director1 2026-03-31 14734440 2024-03-31 14734440 2025-03-31 14734440 2024-04-01 2025-03-31 14734440 frs-core:CurrentFinancialInstruments 2025-03-31
Registered number: 14734440
VPCardio Limited
Unaudited Financial Statements
For The Year Ended 31 March 2026
Sharpe Medical Accounting Ltd
Balance Sheet
Registered number: 14734440
2026 2025
£ £
Fixed assets 604 824
Current assets 179,603 123,026
Prepayments and accrued income 354 312
Creditors: Amounts Falling Due Within One Year (16,581 ) (18,184 )
NET CURRENT ASSETS 163,376 105,154
TOTAL ASSETS LESS CURRENT LIABILITIES 163,980 105,978
Accruals and deferred income (1,380 ) (1,272 )
NET ASSETS 162,600 104,706
CAPITAL AND RESERVES 162,600 104,706

Notes

1. General Information
VPCardio Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14734440 . The registered office is C/O Sharpe Medical Accounting Limited, Normanby Gateway, Lysaghts Way, Scunthorpe, North Lincolnshire, DN15 9YG.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2025: 1)
1 1
3. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 April 2025 Amounts advanced Amounts repaid Amounts written off As at 31 March 2026
£ £ £ £ £
Dr Vasileios Panoulas - 2,944 - - 2,944
The loan was repaid to the company on 31 August 2026.
Page 0
Page 1
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Vasileios Panoulas
Director
27/08/2026